Acute portal vein thrombosis with COVID-19 and cirrhosis

• COVID-19 patients have been reported to develop thrombotic complications. • Portal vein thrombosis is known to be associated with COVID-19. • Anticoagulation in patients with a risk of bleeding needs to be carefully considered.

Detalles Bibliográficos
Autores principales: Miyazato, Yusuke, Ishikane, Masahiro, Inada, Makoto, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7999790/
https://www.ncbi.nlm.nih.gov/pubmed/33816118
http://dx.doi.org/10.1016/j.idcr.2021.e01094
Descripción
Sumario:• COVID-19 patients have been reported to develop thrombotic complications. • Portal vein thrombosis is known to be associated with COVID-19. • Anticoagulation in patients with a risk of bleeding needs to be carefully considered.

Ejemplares similares